Reimbursement strategy for medical technologies in Europe

The reimbursement strategy answers the question of how reimbursement can be established or improved for medical technology.

The reimbursement strategy is always based on the results of a comprehensive reimbursement analysis (procedure coding, payment mechanism, tariffs, policy, and Health Technology Assessment considerations).

Multiple situations may call for reimbursement strategy support, for example:

Technology is new and no coding and reimbursement are available
Coding and reimbursement are available, but the tariff is low and does not cover the cost of a device
Coding and reimbursement are available, and the tariff is sufficient, but there are restrictions on the target population for the procedure

The reimbursement strategy includes an understanding of the relevant pathways (including innovative payment schemes), stakeholders involved, the process, data and evidence requirements, timelines, and deadlines for applications.

What is included in the scope?

MTRC is the leader in reimbursement analysis and strategy for medical technologies in Europe. We provide services to most major corporations, numerous small- and medium-sized enterprises, as well as other life sciences consulting companies. Over many years of practice, MTRC has developed a robust analytical and reporting methodology that answers all your key questions.

The typical scope of the reimbursement strategy project includes:

Problem statement

A clear outline of the market access problems on the market

Ultimate market access goal and key pathways

Ultimate (final) market access objective on the market
Coding and reimbursement, funding, HTA, and innovative payment pathways
Key steps in each process

Stakeholders involved

Applicants, appraising bodies, decision-makers, and decision-influencers

Data and evidence requirements

Specifics of the submission template
Evidence requirements for the process

Timelines and deadlines

Deadlines for applications and timelines for each pathway

The pre-requisite for the majority of the strategy projects is the availability of good information about the current reimbursement situation for a procedure or device: procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations. MTRC provides a service of reimbursement analysis in 34 European countries.

Technological coverage of our services

We provide services for major types of medical technologies:

Implantable devices

Interventional procedures

Non-interventional procedures

In-Vitro diagnostics (IVD) tests

Medical aids

Our team has worked on hundreds of reimbursement/HEOR projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, and endoscopy, amongst others.

Why partner with MTRC?

Be confident in the results

We are accredited by the United Kingdom Accreditation Service (UKAS) as an ISO 9001:2015 certified vendor, specialised in medical technologies market access. Unlike many of our competitors, we dedicate 100% of our time and focus to the area of medical technologies, so that our clients enjoy higher quality services at a lower cost

Avoid the hassle of working with multiple vendors

We specialize in Pan-European projects and worked in 34 countries in Europe. You can save time, effort and money by working with a single experienced vendor vs contracting several consultants individually

Spend less on consulting

We understand the budgetary challenges of the med tech industry and can therefore offer a cost-effective approach to our specialised services. Fourteen percent (14%) of our current business comes from small to medium-sized enterprises (SMEs) – a testament to our unique and personal approach to solve your budgetary challenges

Direct access to senior leadership

Small enough to ensure significant personal attention, and large enough to address your needs, our boutique consultancy guarantees that each project enjoys the attention it deserves with direct access to our senior leaders

Make decisions and advance your business quickly

We appreciate the time-sensitive nature of market access. Being a flexible team, we are not afraid to go beyond regular working hours to meet the high expectations of our clients. For every type of project, we offer the shortest possible turnaround times

Geography of our projects

MTRC is a provider of multi-country European projects. We have worked on the projects in 34 European countries

MTRC in numbers

An extremely specialised boutique consultancy with a global impact

Full-time employees

893

Projects

221

Clients

Regular clients from the top 30 med tech companies

12%

Of business comes from Small to Medium-sized Enterprises (SMEs)

The typical timelines in our proposal are five-eight weeks, depending on the workload of the team. We always deliver projects on time or ahead of schedule. It is also possible to expedite the project (subject to price adjustment) to days or one-two weeks.

Our timelines support your timelines

The analysis is delivered timely to inform your business decisions.

The typical timelines in our proposal are four to five weeks long, depending on the workload of the team. We always deliver projects on time or ahead of schedule.

It is also possible to expedite the project (subject to price adjustment) to mere days or one to two weeks.

How does MTRC perform the analysis and ensure high quality of work?

In order to deliver analysis in multiple and very diverse EU markets, we employ a number of approaches:

We secure access to necessary coding/grouping software and documentation.

In many countries, the software for DRG analysis is only available at a significant cost or available only to hospital providers. We make sure that necessary tools are at our disposal for analysis

We developed know-how of reimbursement analysis in EU markets over many years of consulting practice.

While there are certain general patterns of analysis, which are the same for any system, each country is unique, and a true understanding of the market comes only with the experience

We became a highly standardized organization to ensure the high quality of our work.

We maintain Work Instructions in every country to train new analysts, checklists for daily work, necessary processes, and meetings to learn from mistakes and share knowledge within the organization. We are an ISO 9001:2015 certified organization (with the United Kingdom Accreditation Service, UKAS), which confirms the existence of well-structured processes of quality management

We stay up to date about developments in key markets through our unique paid subscription services Reimbursement and HTA Alerts

We are usually the first to learn about new developments, including procedure coding, payment mechanisms, policies, HTA landscape in general and in relation to individual technologies. We monitor more than 50 organizations every two weeks and more than 200 organizations annually to have a good understanding of all changes in the payment systems

All reports are reviewed by the Director

Being a small, boutique consultancy, we can ensure that our senior leadership expertise is available to every client